Glaukos Investor Relations Material
Latest events
Q2 2025
Glaukos
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Glaukos Corporation
Access all reports
Glaukos Corporation develops and commercializes medical devices and pharmaceuticals for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is known for its minimally invasive surgical technologies and ophthalmic drug delivery platforms. The company is headquartered in Aliso Viejo, California, and its shares are listed on the NYSE.
Key slides for Glaukos Corporation
Investor Presentation
Glaukos Corporation
43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GKOS
Country
🇺🇸 United States